vs

Side-by-side financial comparison of Proto Labs Inc (PRLB) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $139.3M, roughly 1.6× Proto Labs Inc). Proto Labs Inc runs the higher net margin — 5.8% vs 5.8%, a 0.0% gap on every dollar of revenue. On growth, Proto Labs Inc posted the faster year-over-year revenue change (10.4% vs 9.6%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 5.3%).

Protolabs is a company that provides rapid manufacturing of 3D printed, CNC-machined, sheet metal, and injection-molded custom parts for prototyping and production. Markets like medical devices, aerospace, electronics, appliances, automotive and consumer products use these parts. Protolabs' headquarters are located in Maple Plain, Minnesota, with Minnesota-based manufacturing facilities in Plymouth, Brooklyn Park, and Rosemount, along with additional facilities in Nashua, New Hampshire and Ca...

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

PRLB vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.6× larger
UTI
$220.8M
$139.3M
PRLB
Growing faster (revenue YoY)
PRLB
PRLB
+0.8% gap
PRLB
10.4%
9.6%
UTI
Higher net margin
PRLB
PRLB
0.0% more per $
PRLB
5.8%
5.8%
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
5.3%
PRLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
PRLB
PRLB
UTI
UTI
Revenue
$139.3M
$220.8M
Net Profit
$8.1M
$12.8M
Gross Margin
45.6%
Operating Margin
7.1%
7.1%
Net Margin
5.8%
5.8%
Revenue YoY
10.4%
9.6%
Net Profit YoY
125.4%
-42.1%
EPS (diluted)
$0.29
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRLB
PRLB
UTI
UTI
Q1 26
$139.3M
Q4 25
$136.5M
$220.8M
Q3 25
$135.4M
$222.4M
Q2 25
$135.1M
$204.3M
Q1 25
$126.2M
$207.4M
Q4 24
$121.8M
$201.4M
Q3 24
$125.6M
$196.4M
Q2 24
$125.6M
$177.5M
Net Profit
PRLB
PRLB
UTI
UTI
Q1 26
$8.1M
Q4 25
$12.8M
Q3 25
$7.2M
$18.8M
Q2 25
$4.4M
$10.7M
Q1 25
$3.6M
$11.4M
Q4 24
$22.2M
Q3 24
$7.2M
$18.8M
Q2 24
$4.5M
$5.0M
Gross Margin
PRLB
PRLB
UTI
UTI
Q1 26
45.6%
Q4 25
44.2%
Q3 25
45.3%
Q2 25
44.3%
Q1 25
44.1%
Q4 24
42.7%
Q3 24
45.6%
Q2 24
45.0%
Operating Margin
PRLB
PRLB
UTI
UTI
Q1 26
7.1%
Q4 25
5.0%
7.1%
Q3 25
6.5%
11.2%
Q2 25
3.7%
6.9%
Q1 25
3.6%
8.1%
Q4 24
-1.2%
13.6%
Q3 24
6.8%
13.3%
Q2 24
4.8%
4.2%
Net Margin
PRLB
PRLB
UTI
UTI
Q1 26
5.8%
Q4 25
5.8%
Q3 25
5.3%
8.4%
Q2 25
3.3%
5.2%
Q1 25
2.9%
5.5%
Q4 24
11.0%
Q3 24
5.7%
9.6%
Q2 24
3.6%
2.8%
EPS (diluted)
PRLB
PRLB
UTI
UTI
Q1 26
$0.29
Q4 25
$0.25
$0.23
Q3 25
$0.30
$0.33
Q2 25
$0.18
$0.19
Q1 25
$0.15
$0.21
Q4 24
$-0.01
$0.40
Q3 24
$0.29
$0.35
Q2 24
$0.18
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRLB
PRLB
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$124.0M
$162.8M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$683.1M
$335.9M
Total Assets
$778.6M
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRLB
PRLB
UTI
UTI
Q1 26
$124.0M
Q4 25
$128.1M
$162.8M
Q3 25
$119.2M
$169.1M
Q2 25
$103.2M
$70.7M
Q1 25
$96.8M
$96.0M
Q4 24
$103.1M
$172.0M
Q3 24
$100.5M
$161.9M
Q2 24
$112.9M
$115.5M
Total Debt
PRLB
PRLB
UTI
UTI
Q1 26
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Stockholders' Equity
PRLB
PRLB
UTI
UTI
Q1 26
$683.1M
Q4 25
$673.9M
$335.9M
Q3 25
$664.7M
$328.1M
Q2 25
$664.7M
$306.8M
Q1 25
$656.8M
$293.9M
Q4 24
$670.2M
$280.0M
Q3 24
$680.0M
$260.2M
Q2 24
$685.2M
$239.4M
Total Assets
PRLB
PRLB
UTI
UTI
Q1 26
$778.6M
Q4 25
$763.4M
$834.0M
Q3 25
$756.9M
$826.1M
Q2 25
$743.3M
$740.8M
Q1 25
$737.5M
$720.4M
Q4 24
$743.5M
$753.8M
Q3 24
$753.8M
$744.6M
Q2 24
$758.2M
$706.0M
Debt / Equity
PRLB
PRLB
UTI
UTI
Q1 26
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRLB
PRLB
UTI
UTI
Operating Cash FlowLast quarter
$17.5M
$3.1M
Free Cash FlowOCF − Capex
$-19.2M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
10.1%
Cash ConversionOCF / Net Profit
2.16×
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRLB
PRLB
UTI
UTI
Q1 26
$17.5M
Q4 25
$16.5M
$3.1M
Q3 25
$29.1M
$57.1M
Q2 25
$10.6M
$18.1M
Q1 25
$18.4M
$-789.0K
Q4 24
$17.3M
$23.0M
Q3 24
$24.8M
$67.5M
Q2 24
$14.4M
$10.0M
Free Cash Flow
PRLB
PRLB
UTI
UTI
Q1 26
Q4 25
$8.4M
$-19.2M
Q3 25
$25.0M
$40.6M
Q2 25
$9.1M
$6.8M
Q1 25
$17.1M
$-11.7M
Q4 24
$16.5M
$19.6M
Q3 24
$23.2M
$60.0M
Q2 24
$10.2M
$3.0M
FCF Margin
PRLB
PRLB
UTI
UTI
Q1 26
Q4 25
6.2%
-8.7%
Q3 25
18.5%
18.3%
Q2 25
6.7%
3.4%
Q1 25
13.6%
-5.7%
Q4 24
13.5%
9.7%
Q3 24
18.5%
30.6%
Q2 24
8.2%
1.7%
Capex Intensity
PRLB
PRLB
UTI
UTI
Q1 26
Q4 25
5.9%
10.1%
Q3 25
3.0%
7.4%
Q2 25
1.1%
5.5%
Q1 25
1.0%
5.3%
Q4 24
0.7%
1.7%
Q3 24
1.2%
3.8%
Q2 24
3.3%
4.0%
Cash Conversion
PRLB
PRLB
UTI
UTI
Q1 26
2.16×
Q4 25
0.24×
Q3 25
4.03×
3.04×
Q2 25
2.39×
1.69×
Q1 25
5.11×
-0.07×
Q4 24
1.04×
Q3 24
3.44×
3.58×
Q2 24
3.18×
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRLB
PRLB

CNC Machining$63.2M45%
Injection Molding$51.1M37%
3D Printing$20.5M15%
Sheet Metal$4.4M3%
Other Revenue$207.0K0%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons